CD44 Facilitates Epithelial to Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung Cancer
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-17-1279
Full Text
Open PDFAbstract
Available in full text
Date
July 26, 2018
Authors
Publisher
American Association for Cancer Research (AACR)